Effective and economical mycobactericidal disinfectants are needed to kill both Mycobacterium tuberculosis and non-M. tuberculosis mycobacteria. We found that acetic acid (vinegar) efficiently kills M. tuberculosis after 30 min of exposure to a 6% acetic acid solution. The activity is not due to pH alone, and propionic acid also appears to be bactericidal. M. bolletii and M. massiliense nontuberculous mycobacteria were more resistant, although a 30-min exposure to 10% acetic acid resulted in at least a 6-log10 reduction of viable bacteria. Acetic acid (vinegar) is an effective mycobactericidal disinfectant that should also be active against most other bacteria. These findings are consistent with and extend the results of studies performed in the early and mid-20th century on the disinfectant capacity of organic acids. IMPORTANCE Mycobacteria are best known for causing tuberculosis and leprosy, but infections with nontuberculous mycobacteria are an increasing problem after surgical or cosmetic procedures or in the lungs of cystic fibrosis and immunosuppressed patients. Killing mycobacteria is important because Mycobacterium tuberculosis strains can be multidrug resistant and therefore potentially fatal biohazards, and environmental mycobacteria must be thoroughly eliminated from surgical implements and respiratory equipment. Currently used mycobactericidal disinfectants can be toxic, unstable, and expensive. We fortuitously found that acetic acid kills mycobacteria and then showed that it is an effective mycobactericidal agent, even against the very resistant, clinically important Mycobacterium abscessus complex. Vinegar has been used for thousands of years as a common disinfectant, and if it can kill mycobacteria, the most disinfectant-resistant bacteria, it may prove to be a broadly effective, economical biocide with potential usefulness in health care settings and laboratories, especially in resource-poor countries.
| Lista de correo. Espere su aprobación. |
| Consultar este grupo |
jueves, 27 de febrero de 2014
Acetic Acid, the Active Component of Vinegar, Is an EffectiveTuberculocidal Disinfectant
Effective and economical mycobactericidal disinfectants are needed to kill both Mycobacterium tuberculosis and non-M. tuberculosis mycobacteria. We found that acetic acid (vinegar) efficiently kills M. tuberculosis after 30 min of exposure to a 6% acetic acid solution. The activity is not due to pH alone, and propionic acid also appears to be bactericidal. M. bolletii and M. massiliense nontuberculous mycobacteria were more resistant, although a 30-min exposure to 10% acetic acid resulted in at least a 6-log10 reduction of viable bacteria. Acetic acid (vinegar) is an effective mycobactericidal disinfectant that should also be active against most other bacteria. These findings are consistent with and extend the results of studies performed in the early and mid-20th century on the disinfectant capacity of organic acids. IMPORTANCE Mycobacteria are best known for causing tuberculosis and leprosy, but infections with nontuberculous mycobacteria are an increasing problem after surgical or cosmetic procedures or in the lungs of cystic fibrosis and immunosuppressed patients. Killing mycobacteria is important because Mycobacterium tuberculosis strains can be multidrug resistant and therefore potentially fatal biohazards, and environmental mycobacteria must be thoroughly eliminated from surgical implements and respiratory equipment. Currently used mycobactericidal disinfectants can be toxic, unstable, and expensive. We fortuitously found that acetic acid kills mycobacteria and then showed that it is an effective mycobactericidal agent, even against the very resistant, clinically important Mycobacterium abscessus complex. Vinegar has been used for thousands of years as a common disinfectant, and if it can kill mycobacteria, the most disinfectant-resistant bacteria, it may prove to be a broadly effective, economical biocide with potential usefulness in health care settings and laboratories, especially in resource-poor countries.
miércoles, 26 de febrero de 2014
Susceptibility of high-risk human papillomavirus type 16 to clinical disinfectants
Objectives: Little to nothing is known about human papillomavirus (HPV) susceptibility to disinfection. HPV is estimated to be among the most common sexually transmitted diseases in humans. HPV is also the causative agent of cervical cancers and other anogenital cancers and is responsible for a significant portion of oropharyngeal cancers. While sexual transmission is well documented, vertical and non-sexual transmission may also be important.
![]() |
| allaboutcanceronline.info/ |
Results: HPV16 is a highly resistant virus; more so than other non-enveloped viruses previously tested. The HPV16 quasivirions showed similar resistance to native virions, except for being susceptible to isopropanol, the triple phenolic and the lower concentration peracetic acid-silver (PAA-silver)-based disinfectant. Authentic virus and quasivirus were resistant to glutaraldehyde and ortho-phthalaldehyde and susceptible to hypochlorite and the higher concentration PAA-silver-based disinfectant.
Conclusions We present the first disinfectant susceptibility data on HPV16 native virions, which show that commonly used clinical disinfectants, including those used as sterilants in medical and dental healthcare facilities, have no effect on HPV16 infectivity. Policy changes concerning disinfectant use are needed. The unusually high resistance of HPV16 to disinfection supports other data suggesting the possibility of fomite or non-sexual transmission of HPV16.
- Meyers J, Ryndock E, Conway MJ, Meyers C, Robison R. Susceptibility ofhigh-risk human papillomavirus type 16 to clinical disinfectants. J Antimicrob Chemother. 2014 Feb 4.
- Roden RB, Lowy DR, Schiller JT. Papillomavirus is resistant to desiccation. J Infect Dis. 1997 Oct;176(4):1076-9.
martes, 25 de febrero de 2014
Laboratory activities involving transmissible spongiform encephalopathy causing agents
Since the appearance in 1986 of epidemic of bovine spongiform encephalopathy (BSE), a new form of neurological disease in cattle which also affected human beings, many diagnostic and research activities have been performed to develop detection and therapeutic tools. A lot of progress was made in better identifying, understanding and controlling the spread of the disease by appropriate monitoring and control programs in European countries. This paper reviews the recent knowledge on pathogenesis, transmission and persistence outside the host of prion, the causative agent of transmissible spongiform encephalopathies (TSE) in mammals with a particular focus on risk (re)assessment and management of biosafety measures to be implemented in diagnostic and research laboratories in Belgium. Also, in response to the need of an increasing number of European diagnostic laboratories stopping TSE diagnosis due to a decreasing number of TSE cases reported in the last years, decontamination procedures and a protocol for decommissioning TSE diagnostic laboratories is proposed.REFERENCES:
- Amaya Leunda, Bernadette Van Vaerenbergh, Aline Baldo, Stefan Roels, and Philippe Herman. Laboratory activities involving transmissible spongiform encephalopathy causing agents. Prion. 2013 September 1; 7(5): 420–433.
lunes, 24 de febrero de 2014
Primera semana de salud 2014, del 22 al 28 de febrero #vacunas
Del 22 al 28 de febrero las acciones de vacunación se intensificarán a nivel nacional para aplicar vía oral la vacuna Sabin a menores de 5 años. Con esta actividad, ayudarás a mantener erradicada la Polio en nuestro país.
No olvides llevar su Cartilla Nacional de Salud, en ella, el personal de enfermería registrará la aplicación de las vacunas.
Actividades complementarias:
1. Aplicación de todas las vacunas para iniciar o completar esquemas de vacunación en los menores de ocho años de edad, mujeres en edad fértil y grupos poblacionales específicos.
2. Aplicación a embarazadas de la vacuna contra el tétanos, para proteger a sus bebés contra el tétanos neonatal.
3. Distribución de sobres para preparar soluciones hidratantes (Vida Suero Oral).
4. Proporcionar información a los responsables de menores de cinco años para su adecuado uso en el tratamiento de cuadro diarreico.
#Bioseguridad en redes sociales...
viernes, 21 de febrero de 2014
Convocatorias para el VI Simposio #AMexBio #SIBB14
En las instalaciones de la Universidad Autónoma de Nuevo León
Monterrey, Nuevo León, México.
Para propuestas de cursos presimposio a impartirse los días 4 y/o 5 de junio de 2014. Las propuestas serán recibidas del hasta el 1° de marzo de 2014.
viernes, 14 de febrero de 2014
Productos #AMexBio #sibb2014
![]() |
| Miembros AMexBio $130.- (MXP) Público en general $180.- (MXP) + gastos de envío. Adquiérelo en: www.amexbio.wildapricot.org |
viernes, 7 de febrero de 2014
LIBRO: Preparación y repuesta a la entrada de virus #chikungunya en lasAméricas
La fiebre chikungunya (CHIK) es una enfermedad emergente transmitida
por mosquitos y causada por un alfavirus, el virus chikungunya
(CHIKV). Esta enfermedad es transmitida principalmente por los
mosquitos Aedes aegypti y Ae. albopictus, las mismas especies involucradas en la
transmisión del dengue. Estas guías fueron concebidas para ser adaptadas por cada País Miembro. Están
diseñadas para mejorar los conocimientos sobre esta amenaza y para brindar las
herramientas necesarias que permitan establecer las estrategias más adecuadas
para prevenir la importación de CHIKV a la Región, o para su control en caso
de introducción. Proporcionan orientación sobre cómo detectar un brote de
la enfermedad, desarrollar las investigaciones epidemiológicas pertinentes y
prevenir o mitigar la diseminación de la enfermedad en la Región. Preparación y respuesta ante la eventual introducción del virus chikungunya en las Américas
Organización Panamericana de la Salud, © 2011
miércoles, 5 de febrero de 2014
viernes, 31 de enero de 2014
#VIDEOS: Toma de muestras para diagnóstico de #influenza #EPP #Transporte
TOMA DE MUESTRAS NASOFARÍNGEAS
Curso: Capacitación en prevención de infecciones respiratorias #Influenza
Los módulos de capacitación están divididos en 6 presentaciones, complementarias más independientes. Se espera que el comité de control de infecciones o equipo responsable por educación del personal en salud utilicen estas presentaciones para la actualización del personal de salud y comunidad en el tema de medidas de prevención y control de infecciones con enfoque en las enfermedades respiratorias.
Se sugiere también que antes y después de la capacitación los participantes sean evaluados con la "Evaluación de la capacitación" para que se pueda saber cuál es el impacto de la capacitación en el conocimiento del personal de salud sobre el tema.
REFERENCIA:
Curso: Capacitación en prevención de infecciones en los servicios de salud con enfoque en las enfermedades respiratorias
lunes, 27 de enero de 2014
@ssalud_mx activa plan centinela por #Influenza #AH1N1
La Secretaría de Salud (Ssa) espera que se den todavía de 3 a 5 semanas más de aumento en los casos y fallecimientos por influenza, por lo que mantiene en alerta a 583 unidades centinelas en hospitales de primer, segundo y tercer nivel.
REFERENCIAS
- Material para prevención y promoción de la influenza
- Dirección General de promoción a la salud
- Lineamiento para la vigilancia epidemiológica de la influenza
jueves, 23 de enero de 2014
Tuberculosis Laboratory #Biosafety Manual
![]() | |
Laboratory biosafety is the process of applying a combination of administrative controls, containment principles, practices and procedures, safety equipment, emergency preparedness, and facilities to enable laboratory staff to work safely with potentially infectious microorganisms; biosafety also aims at preventing unintentional exposure to pathogens or their accidental release. This manual describes the minimum biosafety measures that should be implemented at the different levels of tuberculosis (TB) testing laboratories to reduce the risk of a laboratory-acquired infection.
Contents
Introduction
1. Risk assessment and the classification of TB laboratories
2. Essential biosafety measures for TB laboratories
3. Low-risk TB laboratories
4. Moderate-risk TB laboratories
5. High-risk TB laboratories (TB-containment laboratories)
6. Safety equipment
7. Personal protective equipment and clothing
8. Plans for emergency preparedness and response
9. References
Tuberculosis Laboratory Biosafety Manual
Geneva: World Health Organization; 2012.
ISBN-13: 978-92-4-150463-8
Copyright and Permissions
PDF version of this title (929K)
lunes, 20 de enero de 2014
Apoyen a la #AMexBio.
![]() |
| Con membresía $90.- (MXP) Público en general $120.- (MXP) + gastos de envío. Adquiérelo en: www.amexbio.wildapricot.org |
ABSL-4 Aerobiology Biosafety and Technology...
The overall threat of a viral pathogen to human populations is largely determined by the modus operandi and velocity of the pathogen that is transmitted among humans. Microorganisms that can spread by aerosol are considered a more challenging enemy than those that require direct body-to-body contact for transmission, due to the potential for infection of numerous people rather than a single individual. Additionally, disease containment is much more difficult to achieve for aerosolized viral pathogens than for pathogens that spread solely via direct person-to-person contact. Thus, aerobiology has become an increasingly necessary component for studying viral pathogens that are naturally or intentionally transmitted by aerosol. The goal of studying aerosol viral pathogens is to improve public health preparedness and medical countermeasure development. Here, we provide a brief overview of the animal biosafety level 4 Aerobiology Core at the NIH/NIAID Integrated Research Facility at Fort Detrick, Maryland, USA.REFERENCE:
Lackemeyer MG, Kok-Mercado Fd, Wada J, Bollinger L, Kindrachuk J, Wahl-Jensen V, Kuhn JH, Jahrling PB. ABSL-4 Aerobiology Biosafety and Technology at the NIH/NIAID Integrated Research Facility at Fort Detrick. Viruses. 2014 Jan 7;6(1):137-50. doi: 10.3390/v6010137. PubMed PMID: 24402304.
viernes, 10 de enero de 2014
Synthetic biology and biosecurity. From low levels of awareness to a comprehensive strategy
![]() |
| Photo: Mashable |
REFERENCE:
Kelle A. Synthetic biology and biosecurity. From low levels of awareness to a comprehensive strategy. EMBO Rep. 2009 Aug;10 Suppl 1:S23-7.
martes, 7 de enero de 2014
Containing the accidental laboratory escape of potential pandemic influenza viruses.
BACKGROUND:
The recent work on the modified H5N1 has stirred an intense debate on the risk associated with the accidental release from biosafety laboratory of potential pandemic pathogens. Here, we assess the risk that the accidental escape of a novel transmissible influenza strain would not be contained in the local community.
METHODS:
We develop here a detailed agent-based model that specifically considers laboratory workers and their contacts in microsimulations of the epidemic onset. We consider the following non-pharmaceutical interventions: isolation of the laboratory, laboratory workers' household quarantine, contact tracing of cases and subsequent household quarantine of identified secondary cases, and school and workplace closure both preventive and reactive.
RESULTS:
Model simulations suggest that there is a non-negligible probability (5% to 15%), strongly dependent on reproduction number and probability of developing clinical symptoms, that the escape event is not detected at all. We find that the containment depends on the timely implementation of non-pharmaceutical interventions and contact tracing and it may be effective (>90% probability per event) only for pathogens with moderate transmissibility (reproductive number no larger than R₀ = 1.5). Containment depends on population density and structure as well, with a probability of giving rise to a global event that is three to five times lower in rural areas.
CONCLUSIONS:
Results suggest that controllability of escape events is not guaranteed and, given the rapid increase of biosafety laboratories worldwide, this poses a serious threat to human health. Our findings may be relevant to policy makers when designing adequate preparedness plans and may have important implications for determining the location of new biosafety laboratories worldwide.
REFERENCE
1: Merler S, Ajelli M, Fumanelli L, Vespignani A. Containing the accidental laboratory escape of potential pandemic influenza viruses. BMC Med. 2013 Nov 28;11:252
Oversight and Review of Clinical Gene Transfer Protocols
Gene transfer research is a rapidly advancing field that involves the introduction of a genetic sequence into a human subject for research or diagnostic purposes. Clinical gene transfer trials are subject to regulation by the U.S. Food and Drug Administration (FDA) at the federal level and to oversight by institutional review boards (IRBs) and institutional biosafety committees (IBCs) at the local level before human subjects can be enrolled. In addition, at present all researchers and institutions funded by the National Institutes of Health (NIH) are required by NIH guidelines to submit human gene transfer protocols for advisory review by the NIH Recombinant DNA Advisory Committee (RAC). Some protocols are then selected for individual review and public discussion. Oversight and Review of Clinical Gene Transfer Protocols provides an assessment of the state of existing gene transfer science and the current regulatory and policy context under which research is investigated. This report assesses whether the current oversight of individual gene transfer protocols by the RAC continues to be necessary and offers recommendations concerning the criteria the NIH should employ to determine whether individual protocols should receive public review. The focus of this report is on the standards the RAC and NIH should use in exercising its oversight function. Oversight and Review of Clinical Gene Transfer Protocols will assist not only the RAC, but also research institutions and the general public with respect to utilizing and improving existing oversight processes.
REFERENCE:
National Research Council. Oversight and Review of Clinical Gene Transfer Protocols: Assessing the Role of the Recombinant DNA Advisory Committee. Washington, DC: The National Academies Press, 2014.
martes, 31 de diciembre de 2013
viernes, 13 de diciembre de 2013
VIDEO: Películas recomendadas para estas vacaciones
jueves, 5 de diciembre de 2013
Hepatitis C Virus Maintains Infectivity for Weeks
ABSTRACT
Background: Healthcare workers may come into contact with fomites containing
infectious HCV during preparation of plasma, or following placement or removal of
venous lines. Similarly, injection drugs users may come into contact with fomites.
Hypothesizing that prolonged viability of HCV in fomites may contribute significantly to
incidence; we determined the longevity of virus infectivity and the effectiveness of
antiseptics.
Methods: We determined the volume of drops misplaced during transfer of serum or
plasma. Aliquots equivalent to the maximum drop volume of plasma spiked with 2a
HCV reporter virus were loaded into 24-well plates. Plates were stored uncovered at three
temperatures: 4°, 22°, and 37°C for up to 6 weeks before viral infectivity was determined
in a microculture assay.
Results: The mean volume of an accidental drop was 29 μl (min - max of 20 - 33 μl). At
storage temperatures 4° and 22°C, we recovered viable HCV from the low titer spots for
up to 6 weeks of storage. The rank order of HCV virucidal activity of commonly used
antiseptics was bleach (1:10) > cavicide (1:10) > ethanol (70%).
Conclusions:
The hypothesis of potential transmission from fomites was supported by the experimental
results. The anti-HCV activity of commercial antiseptics varied.
Reference
Elijah Paintsil1, Mawuena Binka2, Amisha Patel2, Brett D. Lindenbach3, and Robert Heimer2. Hepatitis C Virus Maintains Infectivity for Weeks after Drying on Inanimate Surfaces at Room Temperature: Implications for Risks of Transmission. JID 2013.
http://jid.oxfordjournals.org/content/early/2013/11/22/infdis.jit648.full.pdf
miércoles, 4 de diciembre de 2013
Global Health Risks (2009)
=> DESCARGAR <=
Global Health Risks (2009)
ISBN 978 92 4 156387 1
© World Health Organization 2009
domingo, 24 de noviembre de 2013
#REGENESIS: TV SERIES <= No se la pierdan #Feliz2014
Estas navidades, en las que tendremos mucho tiempo, les recomiento ver la serie de TV "Regenesis".
David Sandstrom es un científico, genetista, virólogo/microbiólogo, jefe de un laboratorio que se dedica a investigar las causas de diversas enfermedades misteriosas, y que originan la muerte de diversas personas. Una combinación de serie policíaca/forense con tonos de microbiología. Aunque cuenta con algunas inexactitudes científicas, pero considerando el año en que empezó a producirse, logra captar la atención del espectador. No se la pueden perder.
jueves, 21 de noviembre de 2013
Responsible life sciences research for global health security #DURC
Responsible life sciences research for global health security #DURC
Publication details
Publication date: 2010
Languages: English
WHO reference number: WHO/HSE/GAR/BDP/2010.2
#Book : People, pathogens and our planet Vol. 2
This report analyzes and assesses the benefits and the costs of control of an important group of contagious diseases. Zoonotic diseases are caused by pathogens that can infect both animals and humans, resulting in disease outbreaks, including epidemics in humans and epizootics in animals. These diseases account for 70 percent of emerging infectious diseases. In the absence of timely disease control, zoonotic pathogens can cause pandemics, with potentially catastrophic impacts that are global in scale. The report also touches on food safety, but does not cover other risks and opportunities at the interfaces between humans, animals, and the ecosystem, such as food security and pollution. Limiting its focus to this topic matter has important advantages, particularly with respect to immediate relevance and relative simplicity.
=> DESCARGAR <=

















